XNYS
GLOB
Market cap1.60bUSD
Oct 08, Last price
37.05USD
1D
4.40%
1Q
23.66%
Jan 2017
11.09%
IPO
221.89%
Name
Globant SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development lifecycle; GUT Studio, which allows clients to better connect brands to end-consumers through experiential marketing; and Enterprise Studio, which leverages tailored technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, enabling industry-specific fine-tuning, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows that operate across systems, teams, and physical environments. Further, it provides various agentic suites, including GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, which enhances marketing, communications, and advertising with AI at the core, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. The company has a collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.
Related entities
Subsidiaries (7)
BLUECAP MANAGEMENT CONSULTING SL
GLOBANT ESPAÑA SA
GLOBANT INDIA PRIVATE LIMITED
IAFH GLOBANT IT MEXICO S DE RL DE CV
SOFTWARE PRODUCT CREATION SL
Globant UK Limited
SISTEMAS GLOBALES S.A.
Key people
Martin Migoya
Chairman of the Board, Chief Executive Officer · since 2013
Juan Urthiague
Chief Financial Officer · since 2018
Guibert Englebienne
Director - President of Globant X and Globant Ventures - President for Latin America · since 2021
Martin Umaran
Director - Chief Corporate Development Officer & President for EMEA · since 2021
Patricia Pomies
Chief Operating Officer · since 2021
Diego Tartara
Chief Technology Officer · since 2021
Yanina Conti
Chief Accounting Officer · since 2017
Patrici Rojo
General Counsel · since 2021
Wanda Weigert
Chief Brand Officer · since 2018
Lead Independent Director · since 2023
Independent Director · since 2024
Independent Director · since 2020
Andrew McLaughlin
Independent Director · since 2024
Andrea Merhy
Independent Director · since 2022
Independent Director · since 2021
Headquarters & legal address
37A, AVENUE J.F. KENNEDY
LUXEMBOURG, LU L-1855
LU
LUXEMBOURG, LU L-1855
LU
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||